Last reviewed · How we verify

NCT02346097: ElectroCRT

Electrophysiological Optimization of Left Ventricular Lead Placement in CRT

Completed NA Last updated 18 June 2018
What this trial tests

NA trial testing Cardiac Resynchronization Therapy (St. Jude Qaudripolar LV lead) in Congestive Heart Failure in 122 participants. Completed in 7 June 2018.

Timeline
16 February 2015
Primary endpoint
7 June 2018
7 June 2018

Quick facts

Lead sponsorUniversity of Aarhus
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment122
Start date16 February 2015
Primary completion7 June 2018
Estimated completion7 June 2018
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

University of Aarhus

Who can join

40 and older, any sex, with Congestive Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate if "optimal electrical resynchronization" achieved by targeting left ventricular lead placement to the myocardial region with the latest electrical activation combined with post-implant pacemakersettings for narrowing the paced QRS width causes an excess improvement in the pumping function of the heart (the left ventricular ejection fraction) in Cardiac Resynchronization Therapy (CRT)

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. The role of guidance in delivering cardiac resynchronization therapy: A systematic review and network meta-analysis.
    Mehta VS, Ayis S, Elliott MK, Widjesuriya N, et al · · 2022 · cited 6× · PMID 36340494 · DOI 10.1016/j.hroo.2022.07.005
  2. Electrically guided versus imaging-guided implant of the left ventricular lead in cardiac resynchronization therapy: a study protocol for a double-blinded randomized controlled clinical trial (ElectroCRT).
    Stephansen C, Sommer A, Kronborg MB, Jensen JM, et al · · 2018 · cited 6× · PMID 30382923 · DOI 10.1186/s13063-018-2930-y

Verify or expand the search:

Other recruiting trials for Congestive Heart Failure

Currently open trials in the same condition.

Other University of Aarhus trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02346097.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing